AMP Group and 2MC join forces

Amsterdam/Houten, 14 November 2022 – Our portfolio company AMP Group joins forces with medical logistics company 2MC. By working together, which in part has been made possible by Holland Capital, the organization is significantly expanding its position in the medical logistics market. With 2MC, AMP Group is taking its third step in its buy-and-build strategy.


2MC specialises in transporting diagnostic material (e.g. blood, tissues, smear tests) from general practitioners and other medical institutions to laboratories throughout the Netherlands. The company provides transport for pathology, medical microbiology and clinical chemistry. 2MC also transports Covid-19 samples from test locations to laboratories and supplies Covid-19 vaccines and test materials.

The medical logistics market

AMP Group is fully committed to the safe and refrigerated delivery of medicines and valuable products where strict safety requirements, such as identification, must be met. The collaboration with 2MC is the third acquisition in AMP Group’s buy-and-build strategy. Late 2021, AMP Group and Delta Logistics started their collaboration, Delta Logistics is a large independent logistics B2B solutions provider, specialized in active refrigerated delivery of pharmaceutical and veterinary products throughout the Netherlands. Mid 2022, Omega Logistics was acquired by AMP Group. Omega Logistics is a specialized logistics service provider that operates mainly in the pharmaceutical and healthcare sector. With these three acquisitions, AMP Group has attained a leading position in the rapidly growing medical logistics market (B2B and B2C).

Marco van der Klij, Managing Director of AMP Group: “By joining forces with 2MC, we as a group can continue to broaden our logistics services within the medical market. The logistics for diagnostic material are usually arranged in such a way that the collected samples can be processed by the laboratory on the same day. With 2MC on board, we now also have a solution for this. We also see opportunities to use these services for non-medical laboratories.”

Ruud Koreman, General Manager of 2MC: “We have been looking for opportunities to expand in the medical transport segment, for both B2B and B2C.  We have found a strong partner in AMP Group with whom we can realize our growth ambitions. We look forward to leveraging the new opportunities that this collaboration will open up for veterinary and non-medical labs.”

Holland Capital has been actively involved as a shareholder in AMP Group since the end of 2020.

About 2MC

For over twenty years, 2MC has specialized in transporting diagnostic material between medical institutions and laboratories. The organization arranges, among other things, the logistics for the cervical cancer population screening throughout the Netherlands. Fragile materials, such as the Covid-19 vaccines, are transported in a temperature-controlled vehicle, which is either cooled or at room temperature. 2MC offers easy and interesting work for pensioners, who usually find this courier work a nice way to contribute to society while earning some extra money.

About AMP Group

Over the past twenty years, AMP Group has grown from a start-up to a mature company that works for leading customers such as T-Mobile, KPN, Kiwa, ABN-AMRO, International Card Services, hospitals, pharmacies, medical wholesalers and over sixty municipalities. Among other services, AMP Group delivers medicines, telephones and confidential documents that require recipient identification. In addition to its proprietary customer experience and route planning software, the company uses the latest technology in ID authentication, facial recognition and biometric signatures to accurately identify the recipient.

About Holland Capital

Holland Capital has invested responsibly and successfully in more than 150 Dutch SMEs over the past 40 years. With a clear investment strategy Holland Capital is active in the attractive growth markets of Healthcare and Technology. Holland Capital’s experienced and committed investment team understand entrepreneurship. They aim to establish an open, sustainable, and professional relationship with the companies they invest in, with the common goal of achieving growth. Holland Capital is backed by a broad network of successful Healthcare and Technology entrepreneurs.

Holland Capital invests in Hybrid Power Units & Top Systems

Holland Capital invests in Hybrid Power Units & Top Systems

Holland Capital invests in Hybrid Power Units & Top Systems   Amsterdam/Stadskanaal/Bodegraven, April 22, 2024 – Holland Capital invests in Hybrid Power Units ('HPU') and Top Systems ('TS'), both companies supply battery-based energy solutions. Holland...

The YOEP group joins forces with PHHaastrecht

The YOEP group joins forces with PHHaastrecht

The YOEP group joins forces with PHHaastrecht   Amsterdam, April 15, 2024 – Our participation the YOEP group will continue together with PHHaastrecht. By joining forces, made possible by Holland Capital, the YOEP group strengthens its youth and adult mental...

Interview with Margot Engels

Interview with Margot Engels

Investing in healthcare has pros and cons. In addition to the financial aspect, social responsibility is at least as important. Substantive knowledge of the product, the sector and market movements are therefore essential, as Margot Engels also knows.

Kids Lodge Acquires BSO Wijs

Kids Lodge Acquires BSO Wijs

Kids Lodge Acquires BSO Wijs   Amsterdam/Houten, March 22, 2024 – Our portfolio company Kids Lodge has acquired the childcare organization BSO Wijs. The acquisition allows Kids Lodge to further expand its childcare activities in the Utrecht region. With 10...

Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 311 94 11


Inselstraße 34
40479 Düsseldorf
+49 (0) 211 43 63 69 01